Are you aware of how India contributes to a world victory in the war against cancer? Oncology drug manufacturers in India are spearheading efforts to make quality, accessible cancer drugs globally. Demand for affordable oncology medicines is surging in India …

Read More

Cancer is surely one of the biggest and toughest conditions in contemporary medicine. The process of finding and developing effective antitumor drugs is as challenging as the process of cancer drug manufacturing companies, requiring expertise, technology, and accuracy.   This ...

Read More

The pharma contract manufacturing industry is expected to experience tremendous growth, increasing to $319.6 billion in 2029. This growth is attributed to the rising cost of drug development, increased demands for generics, and fast-paced technological advancement. With these changes shaping the industry, …

Read More

Is third-party manufacturing the future of pharma? Driven by a push toward cost-saving, specialization, and strict regulatory demands, the pharmaceutical industry is shifting gears fast. Global contract manufacturing is projected to grow from $344.92 billion in 2023 to $604.11 billion …

Read More

How does one turn a promising gene therapy from a concept in the lab into a life-altering medicine for millions? All drugs face complex journeys from the laboratory to the market, but cell and gene therapies require specific differentiated expertise ...

Read More

The pharmaceutical industry is rapidly evolving, with an increasing demand for innovative therapies, particularly in specialized sectors like oncology. Growing pharmaceutical companies face significant challenges in scaling up production while ensuring the highest standards of quality and compliance. This is ...

Read More

The innovations from oncology pharmaceutical companies over recent decades have dramatically changed cancer treatment. Furthermore, new therapies developed by companies have prolonged patients' lives and improved their quality of life. Read further to learn more about the influence of cancer ...

Read More

Diabetes already causes an epidemic worldwide, with 578 million expected by 2030 and 700 million in 2045. In the backdrop of the ever-growing prevalence of diabetes, pharma third-party manufacturing companies face various challenges like high R&D costs, regulatory hurdles, and ...

Read More

In the rapidly growing pharmaceutical industry, companies always seek the best CDMO services that help them improve and streamline their drug creation process. These services offer support in research, expertise, and infrastructure, thus reducing delays that could otherwise affect the ...

Read More